altair_8k-050410.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC  20549
____________

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report (date of earliest event reported):  May 4, 2010
 
Altair Nanotechnologies Inc.
(Exact Name of Registrant as Specified in its Charter)
 

Canada
  
1-12497
  
33-1084375
(State or other jurisdiction of
  
(Commission
  
(IRS Employer
incorporation or organization)
  
File Number)
  
Identification No.)
 

204 Edison Way
Reno, NV
  
89502
(Address of Principal Executive Offices)
  
(Zip Code)

 
Registrant's Telephone Number, Including Area Code:
(801) 858-3750
 
 
N/A
(Former name, former address, and formal fiscal year, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

[ ]      Written  communications  pursuant to Rule 425 under the  Securities Act  (17 CFR 230.425)

[ ]      Soliciting  material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ]      Pre-commencement  communications  pursuant to Rule  14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[ ]      Pre-commencement  communications  pursuant to Rule  13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)



TABLE OF CONTENTS


Item 7.01
Regulation FD Disclosure

Item 9.01
Exhibits

SIGNATURES


EXHIBIT INDEX

EX. 99.1
Press Release
 
 
2

 
Item 7.01    Regulation FD Disclosure.

On May 4, 2010 Altair Nanotechnologies Inc. (the "Company") issued a press release announcing signing of Product Purchase Agreement with Proterra LLC.  A copy of the press release is furnished as Exhibit 99.1 to this Current Report.

The information set forth in this Item 7.01 and Exhibit 99.1 attached hereto is intended to be furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act or the Securities Exchange Act, except as expressly set forth by specific reference in such filing.

Item 9.01    Financial Statements and Exhibits.

(d) 
Exhibits.

99.1 
Press release issued by Altair Nanotechnologies, Inc. dated May 4, 2010 entitled “Altair Nanotechnologies Receives New $850,000 Purchase order From Proterra Inc.”


3
 
SIGNATURES
Pursuant to the requirements of the Securities Exchange of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  Altair Nanotechnologies Inc.  
       
       
       
Dated: May 4, 2010  
By:
/s/ John Fallini  
    John Fallini, Chief Financial Officer  

 
     
 
4